Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00364611
Status:
COMPLETED
Last Update Posted:
2012-08-23
First Post:
2006-08-14
Brief Title:
Pilot Study of Docetaxel Bevacizumab - Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer
Sponsor:
Sanofi
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
DOCET_L_00712
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sanofi
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None